» Articles » PMID: 11991887

Heterozygosity for a Surfactant Protein C Gene Mutation Associated with Usual Interstitial Pneumonitis and Cellular Nonspecific Interstitial Pneumonitis in One Kindred

Overview
Specialty Critical Care
Date 2002 May 7
PMID 11991887
Citations 253
Authors
Affiliations
Soon will be listed here.
Abstract

Familial pulmonary fibrosis is a heterogeneous group of interstitial lung diseases of unknown cause that is associated with multiple pathologic subsets. Mutations in the surfactant protein C (SP-C) gene (SFTPC) are associated with familial desquamative and nonspecific interstitial pneumonitis. Genetic studies in familial usual interstitial pneumonitis have been inconclusive. Using a candidate gene approach, we found a heterozygous exon 5 + 128 T-->A transversion of SFTPC in a large familial pulmonary fibrosis kindred, including adults with usual interstitial pneumonitis and children with cellular nonspecific interstitial pneumonitis. The mutation is predicted to substitute a glutamine for a conserved leucine residue and may hinder processing of SP-C precursor protein. SP-C precursor protein displayed aberrant subcellular localization by immunostaining. Electron microscopy of affected lung revealed alveolar type II cell atypia, with numerous abnormal lamellar bodies. Mouse lung epithelial cells transfected with the SFTPC mutation were notable for similar electron microscopy findings and for exaggerated cellular toxicity. We show that an SFTPC mutation segregates with the pulmonary fibrosis phenotype in this kindred and may cause type II cellular injury. The presence of two different pathologic diagnoses in affected relatives sharing this mutation indicates that in this kindred, these diseases may represent pleiotropic manifestations of the same central pathogenesis.

Citing Articles

Spatial transcriptomics identifies molecular niche dysregulation associated with distal lung remodeling in pulmonary fibrosis.

Vannan A, Lyu R, Williams A, Negretti N, Mee E, Hirsh J Nat Genet. 2025; 57(3):647-658.

PMID: 39901013 PMC: 11906353. DOI: 10.1038/s41588-025-02080-x.


Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium.

Bridges J, Vladar E, Kurche J, Krivoi A, Stancil I, Dobrinskikh E J Clin Invest. 2025; 135(1).

PMID: 39744946 PMC: 11684817. DOI: 10.1172/JCI183836.


Common Mutations in the Surfactant Protein-C Gene in Iranian Patients with Diffuse Parenchymal Lung Disease.

Pourabdollah Toutkaboni M, Askari E, Heshmatnia J, Rezaei M, Hasanzad M, Dorudinia A Tanaffos. 2024; 23(1):65-72.

PMID: 39703441 PMC: 11655001.


Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.

Di X, Li Y, Wei J, Li T, Liao B Adv Sci (Weinh). 2024; 12(3):e2410416.

PMID: 39665319 PMC: 11744640. DOI: 10.1002/advs.202410416.


Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice.

Predella C, Lapsley L, Ni K, Murray J, Liu H, Motelow J Res Sq. 2024; .

PMID: 39315275 PMC: 11419168. DOI: 10.21203/rs.3.rs-4673915/v1.